Concepedia
Statistics
Publications
10
Citations
621
H-Index
Active since
2006
Affiliations
AstraZeneca (United Kingdom)(Current)
University of Liverpool
AstraZeneca (Singapore)
Asana Biosciences (United States)
James Sherwood is an author at AstraZeneca (United Kingdom) specializing in medicine, molecular oncology, and genetics.
Publications per year
2006–2025
A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples
Gillian Ellison, Emma Donald, Gael McWalter et al. · Journal of Experimental & Clinical Cancer Research · 2010 · 153 citations · Full text
Medicine, Genetics, Oncology +17
Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC)
James Sherwood, Claire Corcoran, Helen Brown et al. · PLoS ONE · 2016 · 149 citations · Full text
Medicine, Molecular Genetics, Oncology +17
Ultrasensitive Detection of Multiplexed Somatic Mutations Using MALDI-TOF Mass Spectrometry
Michael Mosko, Aleksey Nakorchevsky, Eunice Flores et al. · Journal of Molecular Diagnostics · 2015 · 84 citations
Medicine, Genetics, Molecular Genetics +11
Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster
Ana Alfirevic, Tracy Mills, Pauline Harrington et al. · Pharmacogenetics and Genomics · 2006 · 62 citations
Medicine, Genetics, Pharmacology +13
AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: Two randomized phase I trials
Javier Armisen, Mitra Rauschecker, Janeli Sarv et al. · Journal of Hepatology · 2025 · 53 citations
Life Sciences, Genetics, Molecular Genetics +4
1–5 of 10